Andrea Tomasella Selected Research

isopeptidase

7/2016	The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells.
2/2015	Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Tomasella Research Topics

Disease

3	Glioblastoma (Glioblastoma Multiforme) 02/2015 - 11/2009
2	Neoplasms (Cancer) 02/2015 - 12/2013
2	Necrosis 09/2014 - 11/2009
1	Leukemia 07/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2016

Drug/Important Bio-Agent (IBA)

2	UbiquitinIBA 07/2016 - 11/2009
2	Bortezomib (Velcade)FDA Link 07/2016 - 11/2009
2	isopeptidaseIBA 07/2016 - 02/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2016 - 11/2009
1	Deubiquitinating EnzymesIBA 02/2015
1	2,3-dimethoxy-1,4-naphthoquinoneIBA 09/2014
1	Actin Depolymerizing Factors (Cofilins)IBA 09/2014
1	HMGB1 Protein (HMG1)IBA 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014
1	Caspase 2IBA 01/2014
1	CholesterolIBA 01/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 12/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013
1	CaspasesIBA 11/2009
1	Glutathione (Reduced Glutathione)IBA 11/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 07/2016
1	Therapeutics 12/2013